Company news

SI-BONE, Inc. news in 2024

SI-BONE, Inc.'s news releases, calls and decks from 2024, newest first.

View company

SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024

November 19, 2024

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance

November 11, 2024

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™

November 4, 2024

SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

October 21, 2024

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation

October 9, 2024

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

August 21, 2024

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

August 19, 2024

SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024

August 5, 2024

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024

August 4, 2024

SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024

July 14, 2024

SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024

June 4, 2024

SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures

May 6, 2024

SI-BONE, Inc. Reports Financial Results for the First Quarter 2024

May 5, 2024

SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

April 28, 2024

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024

April 14, 2024

SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024

March 3, 2024

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance

February 25, 2024

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

February 4, 2024

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

January 29, 2024

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

January 7, 2024

Calls in 2024

Decks in 2024